Laboratory Biosafety

Every clinical virology laboratory works with material that can infect the people who handle it, and biosafety is the set of practices that keeps that material contained. The organising principle is that containment is scaled to the hazard of the agent: a respiratory swab and a suspected Ebola specimen do not demand the same precautions.

A second principle is that containment protects three things at once: the worker at the bench, the environment and community beyond the laboratory walls, and the integrity of the specimen and result that clinical care depends on. The measures below, from the way agents are graded to the cabinets, packaging and law that surround them, all serve those two ideas.

Risk groups and containment levels

Agents are ranked by the danger they pose. The World Health Organization sorts them into four risk groups (RGs) on two axes, the risk to the individual worker and the risk to the surrounding community, modified by whether effective treatment and prevention exist. South Africa’s Regulations for Hazardous Biological Agents use a near-identical scheme of four hazard groups.

Group	Individual and community risk	Effective prophylaxis or treatment	Examples
1	Unlikely to cause human disease	Not applicable	Non-pathogenic laboratory strains
2	May cause disease; unlikely to spread widely	Usually available	Most respiratory and enteric viruses, HIV serology work
3	May cause severe disease; limited community spread	Available	Concentrated HIV or hepatitis B cultures, SARS-CoV-2 culture
4	Severe disease; readily transmissible	Usually none	Ebola, Marburg, Lassa and other viral haemorrhagic fever agents

The decisive point, and the reason the modern framework works the way it does, is that the risk group of an agent does not by itself dictate the biosafety level of the work. Real risk depends on the agent plus the procedure performed, the competence of the person performing it, and the environment. Culturing a litre of virus and running a sealed molecular assay on the same agent carry very different risks.

For this reason the fourth edition of the WHO biosafety manual replaced the old automatic mapping of risk group onto a fixed biosafety level (BSL) ladder with a risk-based approach. Because most laboratory-acquired infections trace to human factors rather than engineering failure, the framework now defines three graded tiers of control:

• Core requirements: the minimum measures that make any work with biological agents safe, built on good microbiological practice and procedure.
• Heightened control measures: added where a risk assessment shows the core requirements alone are insufficient.
• Maximum containment: the work formerly labelled BSL-4, applying the most stringent measures of all for agents that are highly transmissible and untreatable.

The familiar laboratory levels remain a useful shorthand for facilities, and the South African regulations grade their containment requirements across levels 2 to 4, splitting level 3 by whether the agent is airborne.

Containment feature	Level 2	Level 3	Level 4
Typical work	Group 2 agents	Group 3 agents	Group 4 agents
Primary barrier	Cabinet for aerosol-generating steps	Biological safety cabinet mandatory	Class III cabinet or suit
Air handling	General ventilation	Inward airflow, HEPA on extract	Negative pressure, double HEPA
Access	Standard	Controlled, airlock	Airlock, shower on exit
Sealable for fumigation	No	Where needed	Yes

Level 4 in South Africa exists at the National Institute for Communicable Diseases (NICD), the only maximum-containment virology facility on the African continent.

Laboratory hazards and the risk assessment

The hazards of the virology bench are defined by how an agent reaches the worker, by one of four routes:

• Percutaneous: needlestick and other sharps injuries.
• Mucosal: splashes to the eye, nose or mouth.
• Respiratory: inhaled aerosols and droplets generated by centrifuging, pipetting, vortexing and uncapping.
• Ingestion: hand-to-mouth transfer, historically from mouth pipetting.

Biological agents differ from chemical hazards in one important respect: they replicate, so a minute inoculum can establish systemic disease, and an infected worker can become a source for others. Healthcare and laboratory staff are consistently the highest-risk occupational group for these exposures.

Controlling them begins not with a rule book but with a risk assessment, the engine of the whole system. The WHO framework runs a five-step cycle:

1. Gather information on the agents, procedures, equipment and people involved.
2. Evaluate the risks of exposure or release and their likely consequences.
3. Develop a control strategy that fits locally available resources.
4. Select and implement the measures, checking that residual risk is now acceptable.
5. Review periodically, and after any change or incident.

The assessment is a repeated cycle, not a single event.

The measures it selects follow the hierarchy of controls, strongest first:

Control tier	Action	Laboratory example
Elimination or substitution	Removes or downgrades the hazard	Inactivated agent, or a molecular assay instead of culture
Engineering controls	Isolates the hazard at source	Biological safety cabinet, sharps containers
Administrative controls	Governs how the work is done	Standard operating procedures, training, vaccination
Personal protective equipment (PPE)	Last-line personal barrier	Gloves, gown, eye protection, respirator

The order matters. The higher tiers remove or contain the hazard for everyone in the room, whereas PPE protects only the individual, and only when correctly selected, fitted and removed, which is why it is the last line and never the first.

Underpinning all handling are standard precautions, the working assumption that every specimen may be infectious. They extend the older concept of universal precautions, which treated all blood and body fluids as potentially carrying HIV and hepatitis B virus (HBV), to cover all body fluids, non-intact skin and mucous membranes regardless of the known diagnosis.

Primary containment: biological safety cabinets

The biological safety cabinet (BSC) is the principal engineering control against aerosols. It is a ventilated enclosure that uses directional airflow and high-efficiency particulate air (HEPA) filtration, which removes at least 99.97% of particles at 0.3 micrometres, to protect some combination of the operator, the environment and the work itself. Three classes differ in what they protect.

Class	Protects operator	Protects environment	Protects product	Typical use
I	Yes	Yes	No	Aerosol containment where the sample needs no protection
II	Yes	Yes	Yes	Routine virology; the workhorse cabinet
III	Yes	Yes	Yes	Maximum containment; sealed glovebox

A Class I cabinet draws room air inward across the work and exhausts it through a HEPA filter, protecting the worker and environment but letting unfiltered air pass over the sample. A Class II cabinet adds a curtain of HEPA-filtered air flowing down onto the work surface, so it also protects the specimen from contamination; the common Type A2 recirculates most of its air after filtration. A Class III cabinet is a gas-tight, negative-pressure glovebox with the operator working through sealed gloves and all air filtered in and out, reserved for the most dangerous agents.

Three airflow principles explain the protection:

• Inward face velocity at the open front draws air away from the operator.
• Downward laminar flow of filtered air protects the product.
• HEPA-filtered exhaust protects the environment.

Two limitations qualify this. A standard Class II cabinet is not a chemical fume hood: it recirculates air and does not protect against volatile or flammable chemicals, which need a fume hood or a total-exhaust cabinet. And its protection is easily degraded by poor positioning, draughts, rapid arm movements or overloading, so it never replaces good technique. Cabinets are therefore certified on installation, after any move or filter change, and at least annually, testing airflow velocities and HEPA integrity, and are gas-decontaminated before filter maintenance.

Working with category 3 and 4 agents

The higher hazard groups demand a specific approach at the moment a sample arrives. The first defence is recognition: a travel and exposure history that raises a viral haemorrhagic fever, or a request that names a Group 3 or 4 agent, should trigger the high-hazard pathway before the specimen is opened. Routine automated analysers and open benchwork are exactly where an unrecognised Group 4 specimen does its damage.

The governing rule is to assess before handling and consult early. For a suspected Group 4 infection the laboratory does not proceed on its own: it consults the reference laboratory, and the specimen is either handled under maximum containment or referred.

Where essential routine tests must still be done on a possible viral haemorrhagic fever patient, they are minimised, performed under heightened containment with the analyser and waste treated as infectious, or deferred until the agent is excluded. The clinical management of the patient, meaning isolation, personal protective measures and treatment on the ward, is a distinct discipline handled within the viral haemorrhagic fever pathway.

A common high-hazard event is a spill. For a spill of a high-titre specimen such as a concentrated HIV sample, the response is ordered and unhurried:

• Evacuate and warn the people in the area.
• Let the aerosol settle rather than rushing back in.
• Refer anyone exposed for medical assessment, and inform the supervisor and biosafety officer.
• Decontaminate in PPE: cover the spill with absorbent material, apply a suitable disinfectant working from the outside inward, and allow the full contact time before clearing it.

The underlying attitude is that of universal precautions: the material is assumed infectious throughout.

Transport of infectious substances

Once a specimen must leave the building, international rules take over, and they turn on a two-category split. Category A covers material known or reasonably expected to contain an agent capable of causing permanent disability or life-threatening disease in otherwise healthy people; Category B covers infectious material that does not meet that bar. The category sets the United Nations (UN) shipping number, the packing instruction and the paperwork.

Feature	Category A	Category B
UN number	UN2814 (affecting humans)	UN3373
Proper shipping name	Infectious substance, affecting humans	Biological substance, Category B
Packing instruction	P620 / IATA PI 620	P650 / IATA PI 650
Shipper certification	Required	Good practice
Virology examples	VHF specimens; cultures of HIV or HBV	Diagnostic specimens for HIV or hepatitis testing

All infectious material moves under the triple-packaging system, three nested layers:

• Primary receptacle: a watertight container holding the specimen, wrapped in enough absorbent material to soak up the entire contents if it leaks.
• Secondary packaging: a watertight container enclosing the primary, with the itemised list of contents placed between it and the outer package.
• Outer packaging: a rigid container carrying the certified UN specification mark for Category A.

Coolants such as dry ice go between the secondary and outer layers.

The practical rule for virology is that everyday diagnostic blood and serum for HIV or hepatitis testing travel as Category B under UN3373, whereas propagated cultures of those viruses, and any viral haemorrhagic fever material, are Category A under UN2814. A suspected viral haemorrhagic fever specimen follows a dedicated Category A route to the national reference laboratory. In South Africa transport also falls under the National Road Traffic Act for road movement and the International Air Transport Association (IATA) rules for air, with laboratory registration and pathogen handling authorised under the National Health Act.

Decontamination and waste

Contaminated material is rendered safe before it leaves the laboratory as waste. The reference method for virological material is moist-heat sterilisation in an autoclave, typically 121 degrees Celsius for 15 minutes under steam pressure, with heat-resistant loads run hotter. Air must be displaced from the chamber because trapped air insulates and creates cold spots, and each cycle is monitored for time, temperature and pressure; spores of Geobacillus stearothermophilus serve as the biological indicator that proves inactivation, while autoclave tape only shows a load was processed.

Waste is then segregated by stream:

• Sharps into puncture-resistant containers, treated as infectious.
• Material for reuse decontaminated before washing.
• Infectious solids decontaminated on site, or held safely for off-site treatment.
• Liquid waste decontaminated before it enters the sewer.

Incineration handles anatomical and other waste unsuitable for autoclaving, under air-quality authorisation. The chemistry of disinfectants, their spectrum, contact times and the choice between agents, is the province of infection prevention and control; at the biosafety level the point is that the correct process is validated, matched to the agent, and applied before disposal.

Audit, non-conformance and incident reporting

A biosafety programme is only as good as its upkeep, which rests on review, reporting and correction. Incident reporting is a duty, not a courtesy: any possible exposure is reported at once, exposed staff are medically assessed, and the event feeds back into the risk assessment, which is reviewed after every incident. Because most laboratory infections arise from human factors such as absent or misused PPE, skipped procedures and undertrained staff, investigation looks for the root cause rather than stopping at the individual error, and closes with a corrective and preventive action that changes the system.

Laboratories test their own compliance through audits. A horizontal audit follows one element (for example every risk assessment, or every training record) across the whole laboratory, while a vertical audit follows a single case or sample through every step it passed. The formal quality-management machinery around accreditation, meaning the ISO 15189 standard and the national accreditation system, belongs to laboratory quality management and is treated as its own subject; the biosafety concern is narrower, that hazards are found, recorded as non-conformances, and corrected in a documented, auditable way.

South African context

In South Africa laboratory biosafety is law. The Regulations for Hazardous Biological Agents, 2022 (Government Notice R1887, Government Gazette 46051, 16 March 2022) were made under the Occupational Health and Safety Act 85 of 1993 and replaced the 2001 regulations. They apply to every workplace where a hazardous biological agent (HBA) is handled or where exposure may occur, and they convert the principles above into enforceable duties on the employer.

Agents are classified into Groups 1 to 4 by the chief inspector; an employer meeting an unlisted agent classifies it provisionally by risk assessment and assigns the higher group when in doubt. On the strength of that assessment, the regulations place concrete duties on the employer:

• Documented risk assessment by a competent person, reviewed at least every 24 months and immediately after any incident, weighing the effect on pregnant and immunocompromised staff.
• Information and annual refresher training for exposed staff.
• Standard precautions and containment matched to the hazard group, with the biohazard sign displayed.
• Effective vaccines offered to non-immune exposed staff.
• Medical surveillance by an occupational health practitioner, beginning within 14 days of starting risk-exposed work and repeated at least every 24 months.
• Record retention over extended periods, with risk-assessment and medical surveillance records held for at least 40 years given the long latency of some infections.

The regulations also carry the transport, labelling and waste duties noted above, directing HBA waste only to sites authorised under the National Environmental Management: Waste Act.

Two older statutes complete the legal frame. The Hazardous Substances Act 15 of 1973 controls the sale, use and disposal of hazardous substances, including radioactive material, while the Foodstuffs, Cosmetics and Disinfectants Act 54 of 1972 governs the manufacture and labelling of disinfectants, and so bears on which products a laboratory may use and the claims they carry. In routine practice within the National Health Laboratory Service (NHLS), these requirements are operationalised through local standard operating procedures, with the NICD providing the country’s maximum-containment reference capacity.

References and recommended reading

World Health Organization. Laboratory biosafety manual. 4th ed. Geneva: World Health Organization; 2020.

Republic of South Africa. Regulations for Hazardous Biological Agents, 2022. Government Notice R1887, Government Gazette No. 46051, 16 March 2022, made under the Occupational Health and Safety Act 85 of 1993.

Department of Employment and Labour. Explanatory notes to the Regulations for Hazardous Biological Agents, 2022. Republic of South Africa; 2022.

Russi M. Biological hazards. In: Levy BS, Wegman DH, Baron SL, Sokas RK, editors. Occupational and Environmental Health: Recognizing and Preventing Disease and Injury. 7th ed. New York: Oxford University Press; 2018.